Key Takeaways Labcorp is emerging as the stronger investment based on valuation, price performance and analyst targets.Hologic is supported by diagnostics and breast health innovation, but macro headwinds remain.Labcorp trades at a lower forward P/S than Hologic while outperforming over the past 12 months.Hologic (HOLX) and Labcorp (LH) are two established MedTech players with a history of collaboration, though each brings distinct strengths. With a market capitalization of $16.71 billion, Hologic specializ ...